NCT01645007 Prevalence of Hepatitis B Infection in the Galilee Region, Israel Status WITHDRAWN Phase N/A
NCT01627340 Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE4
NCT01606163 Safety and Pharmacokinetics Study of Healthy Male Adults When Repeatedly Administered Through Intravenous Injection Status COMPLETED Phase PHASE1
NCT01599130 Efficacy of Peg-interferon α-2a in Hepatitis B Patients Treated by Entecavir Without HBeAg Loss Status UNKNOWN Phase NA
NCT01590654 A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection Status COMPLETED Phase PHASE1
NCT01590641 A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B Status COMPLETED Phase PHASE1
NCT01590615 Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy Status COMPLETED Phase N/A
NCT01580202 Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus Lamivudine Status COMPLETED Phase PHASE3
NCT01574521 Seroepidemiologic Study of Spermatozoal Transmission of Hepatitis B Virus (HBV) Status COMPLETED Phase N/A
NCT01548326 Effects of Short-term Atorvastatin Treatment on Vaccination Efficacy in Nonresponder Persons to Hepatitis B Vaccine Status UNKNOWN Phase PHASE4
NCT01513850 A Confirmatory Study of Hepabulin IV in HBsAg Positive Liver Transplantation Recipients Status COMPLETED Phase PHASE3
NCT01500265 Assessment and Monitoring of Renal Proximal Tubular Tolerance of Nucleoside and Nucleotide Analogues Using Early Screening Tools in Patients Chronically Mono-infected With Hepatitis B Virus Status COMPLETED Phase N/A
NCT01470287 Immunogenicity, Safety and Tolerability of a Fully Liquid Pentavalent (DTwP-Hib-Hep B) Vaccine in Infants 6-8 Weeks of Age Status COMPLETED Phase PHASE3
NCT01463683 Modified Process Hepatitis B Vaccine in Japanese Young Adults (V232-062) Status COMPLETED Phase PHASE3
NCT01457560 Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine Status COMPLETED Phase PHASE3
NCT01457547 Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course Status COMPLETED Phase PHASE4
NCT01457508 Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately Status COMPLETED Phase PHASE3